Michigan Medicaid may require prior authorization for drugs that do not provide rebates to non-Medicaid programs, D.C. federal appeals court affirms April 2. The Pharmaceutical Research & Manufacturers of America's lawsuit against the state argued the policy was not in the "best interest" of Medicaid recipients; the lower court also ruled against PhRMA (1"The Pink Sheet" March 31, 2003, In Brief). The 2appellate court ruling cited the Supreme Court's rejection of PhRMA's challenge to a similar Maine program last year (3"The Pink Sheet" May 26, 2003, p. 23). [Editor's Note: A version of this story first appeared in 4"The Pink Sheet" DAILY April 2. Visit our website, www.ThePinkSheetDAILY.com, to sign up for a free trial.]...

Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.

Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.